{"id":"W1821546071","doi":"10.1200/jco.2014.32.18_suppl.lba6008","title":"A phase 3, multicenter, double-blind, placebo-controlled trial of lenvatinib (E7080) in patients with <sup>131</sup>I-refractory differentiated thyroid cancer (SELECT).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenvatinib; Medicine; Internal medicine; Hazard ratio; Thyroid cancer; Clinical endpoint; Gastroenterology; Refractory (planetary science); Placebo; Progression-free survival; Confidence interval; Oncology; Cancer; Randomized controlled trial; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001506601,0.001677606,0.00182769,0.0003568295,0.0004576061,0.0009094866,0.0008347144,0.001674745,0.005746306],"category_scores_gemma":[0.00111834,0.0006378256,0.001014555,0.000362843,0.001117559,0.0009927072,0.0003773425,0.002380878,0.001131799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007323567,"about_ca_system_score_gemma":0.001434961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000750752,"about_ca_topic_score_gemma":0.001985309,"domain_scores_codex":[0.9995657,0.0002074534,0.00002213976,0.00008896341,0.00003438498,0.00008134831],"domain_scores_gemma":[0.9993855,0.0001217438,0.0001655445,0.00004573756,0.00004087587,0.0002405111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9691772,0.01027898,0.0009122302,0.0004011027,0.0004125225,0.00004877429,0.00006510595,0.0002622504,0.006057134,0.0001092145,0.001281934,0.01099344],"study_design_scores_gemma":[0.9413965,0.05550855,0.001556598,0.00001216859,0.0001452062,0.00003802355,0.00001542162,0.0002208318,0.0004257474,0.00009535319,0.0005768638,0.000008742882],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839414,0.002723355,0.0007501863,0.0007998688,0.0004242447,0.006069397,0.002049121,0.0002191444,0.003023291],"genre_scores_gemma":[0.9832714,0.001603006,0.001476066,0.001587688,0.000350475,0.006817036,0.001882827,0.00003242324,0.002979024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005746306,"threshold_uncertainty_score":0.01922333,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06840121577109488,"score_gpt":0.4262788631778101,"score_spread":0.3578776474067152,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}